- Home
- TTGT vs XOMA Comparison
TTGT vs XOMA Comparison
Compare TTGT & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTGT
- XOMA
- Stock Information
- Founded
- TTGT 1999
- XOMA 1981
- Country
- TTGT United States
- XOMA United States
- Employees
- TTGT N/A
- XOMA N/A
- Industry
- TTGT Telecommunications Equipment
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- TTGT Telecommunications
- XOMA Health Care
- Exchange
- TTGT Nasdaq
- XOMA Nasdaq
- Market Cap
- TTGT 468.3M
- XOMA 457.6M
- IPO Year
- TTGT 2007
- XOMA N/A
- Fundamental
- Price
- TTGT $5.56
- XOMA $37.38
- Analyst Decision
- TTGT Strong Buy
- XOMA Strong Buy
- Analyst Count
- TTGT 5
- XOMA 2
- Target Price
- TTGT $16.40
- XOMA $69.50
- AVG Volume (30 Days)
- TTGT 802.5K
- XOMA 55.4K
- Earning Date
- TTGT 11-10-2025
- XOMA 11-06-2025
- Dividend Yield
- TTGT N/A
- XOMA N/A
- EPS Growth
- TTGT N/A
- XOMA N/A
- EPS
- TTGT N/A
- XOMA N/A
- Revenue
- TTGT $387,100,000.00
- XOMA $44,952,000.00
- Revenue This Year
- TTGT N/A
- XOMA $88.91
- Revenue Next Year
- TTGT $98.75
- XOMA $13.80
- P/E Ratio
- TTGT N/A
- XOMA N/A
- Revenue Growth
- TTGT 50.73
- XOMA 194.98
- 52 Week Low
- TTGT $5.39
- XOMA $18.35
- 52 Week High
- TTGT $33.08
- XOMA $39.92
- Technical
- Relative Strength Index (RSI)
- TTGT 41.96
- XOMA 54.26
- Support Level
- TTGT $5.41
- XOMA $35.00
- Resistance Level
- TTGT $5.75
- XOMA $38.98
- Average True Range (ATR)
- TTGT 0.34
- XOMA 2.07
- MACD
- TTGT -0.03
- XOMA -0.35
- Stochastic Oscillator
- TTGT 18.75
- XOMA 48.27
About TTGT TechTarget Inc.
TechTarget Inc is engaged in the business-to-business (B2B) accelerator, informing and influencing technology buyers and sellers. Through its B2B first-party data and an end-to-end portfolio of data-driven solutions, it services the full B2B product lifecycle for customers from, messaging, and content development to in-market activation via brand, demand generation, purchase intent data, and sales enablement from R&D to ROI.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.